Form 4 Filing for ABEONA THERAPEUTICS INC.

Leila Alland, a director at ABEONA THERAPEUTICS INC., reported the sale of 11,000 shares of Common Stock on June 30, 2026. The shares were sold at a weighted average price of $5.917 per share, with individual transactions ranging from $5.915 to $5.9334. Following these transactions, Ms. Alland directly owns 162,614 shares of the company's stock. This filing, designated as a Form 4, details the changes in beneficial ownership of securities.